Literature DB >> 16701552

Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan.

Di Zhong1, Fumiaki Saito, Yuko Saito, Ayami Nakamura, Teruo Shimizu, Kiichiro Matsumura.   

Abstract

Dystroglycan (DG) complex, composed of alphaDG and betaDG, provides a link between the extracellular matrix (ECM) and cortical cytoskeleton. Although the proteolytic processing of betaDG was reported in various physiological and pathological conditions, its exact mechanism remains unknown. In this study, we addressed this issue using the cell culture system of rat schwannoma cell line RT4. We found that the culture medium of RT4 cells was enriched with the protease activity that degrades the fusion protein construct of the extracellular domain of betaDG specifically. This activity was suppressed by the inhibitor of matrix metalloproteinase-2 (MMP-2) and MMP-9, but not by the inhibitors of MMP-1, MMP-3, MMP-8, and MMP-13. Zymography and RT-PCR analysis showed that RT4 cells secreted MMP-2 and MMP-9 into the culture medium. Finally, active MMP-2 and MMP-9 enzymes degraded the fusion protein construct of the extracellular domain of betaDG. These results indicate (1) that RT4 cells secrete the protease activity that degrades the extracellular domain of betaDG specifically and (2) that MMP-2 and MMP-9 may be involved in this process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16701552     DOI: 10.1016/j.bbrc.2006.05.004

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.

Authors:  Akhilesh Kumar; Shephali Bhatnagar; Ashok Kumar
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

2.  Reduction of α-dystroglycan expression is correlated with poor prognosis in glioma.

Authors:  Xin Zhang; Xiang-Hui Dong; Yue Ma; Lan-Feng Li; He Wu; Min Zhou; Yun-He Gu; Guo-Zhong Li; De-Sheng Wang; Xiao-Feng Zhang; Jing Mou; Ji-Ping Qi
Journal:  Tumour Biol       Date:  2014-08-20

3.  Drp2 and periaxin form Cajal bands with dystroglycan but have distinct roles in Schwann cell growth.

Authors:  Diane L Sherman; Lai Man N Wu; Matthew Grove; C Stewart Gillespie; Peter J Brophy
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

4.  Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy.

Authors:  Hong Li; Ashwani Mittal; Pradyut K Paul; Mukesh Kumar; Daya S Srivastava; Suresh C Tyagi; Ashok Kumar
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

Review 5.  Biological role of dystroglycan in Schwann cell function and its implications in peripheral nervous system diseases.

Authors:  Toshihiro Masaki; Kiichiro Matsumura
Journal:  J Biomed Biotechnol       Date:  2010-06-15

6.  Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy.

Authors:  Hong Li; Ashwani Mittal; Denys Y Makonchuk; Shephali Bhatnagar; Ashok Kumar
Journal:  Hum Mol Genet       Date:  2009-04-28       Impact factor: 6.150

7.  Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding.

Authors:  Georgina S Butler; Richard A Dean; Eric M Tam; Christopher M Overall
Journal:  Mol Cell Biol       Date:  2008-05-27       Impact factor: 4.272

8.  Matrix metalloproteinase (MMP) 9 transcription in mouse brain induced by fear learning.

Authors:  Krishnendu Ganguly; Emilia Rejmak; Marta Mikosz; Evgeni Nikolaev; Ewelina Knapska; Leszek Kaczmarek
Journal:  J Biol Chem       Date:  2013-05-28       Impact factor: 5.157

Review 9.  Wasting mechanisms in muscular dystrophy.

Authors:  Jonghyun Shin; Marjan M Tajrishi; Yuji Ogura; Ashok Kumar
Journal:  Int J Biochem Cell Biol       Date:  2013-05-11       Impact factor: 5.085

10.  Albumin modulates the production of matrix metalloproteinases-2 and -9 in podocytes.

Authors:  Zhan Fang; Fangfang He; Shan Chen; Xifeng Sun; Zhonghua Zhu; Chun Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.